Related Experiment Video
Updated: Jul 4, 2026
05:19
Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder
Published on: July 7, 2023
Depression in Parkinson's disease: an EEG frequency analysis study
S R Filipović1, N Covicković-Sternić, M Stojanović-Svetel
1Department of Neurology, Faculty of Medicine, University of Belgrade, ul. Dr. Subotica 6, 11000 Beograd, Yugoslavia.
Parkinsonism & Related Disorders
|July 2, 2008
Summary
Depression in Parkinson's disease (PD) may have unique brainwave patterns. Depressed PD patients showed distinct electroencephalography (EEG) alpha wave differences compared to non-depressed PD patients.
Area of Science:
- Neuroscience
- Neurology
- Psychiatry
Background:
- Depression frequently co-occurs with Parkinson's disease (PD).
- The underlying neurobiological mechanisms of depression in PD remain unclear.
- Identifying specific biomarkers could aid in understanding and treating PD-related depression.
Purpose of the Study:
- To investigate distinct electroencephalography (EEG) spectral characteristics differentiating depressed from non-depressed individuals with Parkinson's disease.
- To explore the neurobiological underpinnings of depression within the context of Parkinson's disease.
Main Methods:
- Studied 24 idiopathic Parkinson's disease patients, divided into depressed and non-depressed groups.
- Recorded 16-channel electroencephalography (EEG) after a 24-hour medication withdrawal.
- Analyzed EEG data using Fast Fourier Transformation to assess spectral power and topography.
Main Results:
- Depressed Parkinson's disease patients exhibited significantly reduced alpha1 (7.5-10Hz) absolute and relative power.
- Increased relative power in the alpha2 (10.5-13Hz) band was observed in depressed PD patients.
- Topographic analysis revealed an anterior shift of alpha1 power maximum in depressed PD patients, differing from controls and non-neurological depressed individuals.
Conclusions:
- Distinct spectral EEG patterns characterize depression in Parkinson's disease.
- The neurobiology of depression in PD appears to be a complex interaction, not merely additive.
- These findings suggest a unique neurobiological substrate for depression in Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...